A compound of formula (I): ** (See formula) ** or a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof, in which: L1 is independently L4-O or O-L4； L2 is independently a 0-2 Rc substituted hydrocarbon linker or a 0-2 Rc substituted hydrocarbon heteroatom linker； wherein said hydrocarbon linker has one to six carbon atoms and can be linear or branched, saturated or unsaturated； and said hydrocarbon-heteroatom linker has one to four carbon atoms and a group selected from O, -CO-, S, -SO-, -SO2-, NH and N (C1-4 alkyl)； L4 is independently a hydrocarbon bond or linker； wherein said hydrocarbon linker has one to four carbon atoms and can be linear or branched； R1 is independently selected from: C6-10 carbocycle and a 5 to 10 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NRb, O, and S (O) p； wherein said carbocycle and heterocycle are substituted with 0-4 R3 and 0-1 R4； R2 is independently selected from: CO2H and -CONHSO2 (C1-4 alkyl)； R3, at each occurrence, is independently selected from: halogen, C1-6 alkyl, C1-4 alkoxy, C1-4 alkylthio, C1-4 haloalkyl, C1-4 haloalkoxy, C1-4 haloalkylthio, and NO2； R4 is independently -L3-R5； L3 is independently selected from: a bond, O, and C (= O)； R5 is independently selected from: phenyl and a 5-6 membered heteroaryl comprising carbon atoms and 1-4 heteroatoms selected from N, NRb, O, and S (O) p； wherein each residue on the ring is substituted with 0-2 Ra； Ra, at each occurrence, is independently selected from: halogen, C1-4 alkyl, C1-4 alkoxy and C1-4 haloalkyl； Rb, at each occurrence, is independently selected from: H, C1-4 alkyl, and - (CH2) 0-2- (phenyl substituted with 0-3 Rd)； Rc, at each occurrence, is independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, and C1-4 alkoxy； Rd, at each occurrence, is independently selected from: halogen, C1-4 alkyl, C1-4 alkoxy and C1-4 haloalkyl； and p, independently in each case, is selected from 0, 1 and 2.Un compuesto
